Form 4 holding
Director, 10%+ Owner
BridgeBio Oncology Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 5,952,356
- Estimated value
- $63,793,185
- Report date
- 11 Aug 2025
- Price
- $10.72
- Ownership
- Via Master Fund